Managing elderly people's osteoporosis. Why? Who? How?

摘要: OBJECTIVE: To guide family physicians through assessment of why treating elderly people's osteoporosis is necessary, who to treat, and how treat in a practical way. QUALITY OF EVIDENCE: Evidence the efficacy treatment for shown by reduced probability fracture. This can be ascertained direct evaluation bisphosphonates, calcium, calcitonin, or indirectly ascertaining benefit bone mineral density hormone replacement therapy (HRT) exercise. MAIN MESSAGE: Unless medically contraindicated, all people should take supplementary vitamin D (800 IU/d) calcium (1500 mg/d). Those with risk factors (e.g., smoking, thinness, previous fracture when older than 50 years, first-degree relatives steroid use) have measurement. meeting World Health Organization criteria also treated HRT bisphosphonates possibly selective estrogen receptor modulators. CONCLUSIONS: Good evidence indicates that adequate prevent fractures thus reduce associated morbidity mortality among vulnerable people. Because prevalence osteoporosis, onus falls on front-line managers.